Personalized Medicine Conferences

Biomarker Conferences | Personalized Medicine Conferences

Is your meeting listed?

Submit a conference announcement

The 2nd Annual World Congress Leadership Summit on Personalized Medicine and Medical Policy
The 2nd Annual World Congress Leadership Summit on Personalized Medicine and Medical Policy convenes senior executives from health plans to discuss the advances in medical genetics and the marketing opportunities being created. As new advances in personalized medicine will revolutionize the delivery of health care they also raise a number of questions that health plans need to address on identifying which tests are clinical viable and offer positive outcomes.

May 21 - 22, 2012, Washington, DC, USA

4th Annual Personalized Medicine Conference
The 4th Annual Personalized Medicine Conference, presented by Arrowhead, will tackle the issues driving as well as restraining the clinical delivery of personalized medicine, including coding and reimbursement, the economics of personalized medicine and medicare policy.

September 12-13, 2012, Boston, MA, USA

The ADAPT 2012 Accelerating Development & Advancing Personalized Therapy Congress
ADAPT 2012, presented by Cambridge Healthtech Institute, includes seven concurrent tracks: (1) Implementing Personalized Medicine; (2) Clinical Trial Designs for Personalized Therapy; (3) Clinical Biomarkers; (4) Next-Generation Non-Invasive Molecular Diagnostics; (5) Translational Cancer Medicine; (6) Circulating Tumor Cells; and (7) Exosomes and Microvesicles. ADAPT 2012 attracts a balanced mix of delegates from pharma and diagnostic companies, clinical organizations, academia, and government, providing a unique opportunity to learn from the thought leaders, network with the decision makers, and discover actionable implementation strategies bridging drug and diagnostic development.

September 19-21, 2011, Washington D.C., USA

Past Conferences


Personalized Medicine World Conference PMWC 2011
PMWC 2011 is the only fully integrated conference on Personalized Medicine which brings together all aspects of business, government, healthcare-delivery, research and technology all in one information-rich, two-day conference.

January 18 - 19, 2011, Silicon Valley, California, USA

18th International Molecular Med Tri-Conference
Attend. Discover. Apply. The one scientific event for cutting-edge research, trends and analysis. The future holds great promise for molecular medicine, however the demand for results today is ever mounting, from both patients and businesses alike. The Molecular Med Tri-Con is the place to find the tools to turn 'someday' into 'now'.

February 23 - 25, 2011, San Francisco, California, USA

Molecular Diagnostics Conference
Sessions for the conference include: the quest towards personalized medicine, regulatory hurdles to overcome, companion diagnostics – successes and future challenges, emerging technologies and discoveries and future trends and emerging targets.

March 7 - 8, 2011, Philadelphia, Pennsylvania, USA

Personalized Medicine And Diagnostics Europe
PM and Dx 2011 is the most focused meeting for the pharmaceutical and diagnostics industry and enables key decision makers to discuss the central business opportunities and developments set to dominate 2011.

March 9 - 10, 2011, London, UK

Companion Diagnostics Summit Europe
This meeting steps away from the larger, more generic biomarker or personalised medicine conferences. The aim is to discuss the opportunities and challenges specifically focused around companion diagnostic development. Because that's the next crucial step to master if we are going to achieve patient stratification.

March 22 - 24, 2011, Frankfurt, Germany

3rd Annual Forum for Payers on Personalized Medicine
The conference focuses on evaluating clinical utility and cost-effectiveness of diagnosis and treatment. Topics being addressed include: FDA regulatory expectations for personalized medicine, fundamentals for understanding and managing genomics, changing the environment of personalized medicine through improving reimbursement policies, genomics of oncology and the creation of personalized therapeutic options, effective technology to improve outcomes, and evidence-based outcomes and the utilization of patient databases.

March 24 - 25, 2011, Washington, DC, USA

3rd Annual Personalized Medicine Partnerships Conference
Arrowhead's 3rd Annual Personalized Medicine Partnerships Conference will shed light on issues of paramount importance to the future of personalized medicine, including the importance of Rx-Dx partnerships, clinical utility/validation, adoption and the commercial realities of personalized medicine in the global healthcare marketplace.

April 11 - 12, 2011, Washington, DC, USA

World Pharmacogenomics Summit
Advanced molecular profiling strategies for increased drug success. This meeting is designed specifically to ensure you give your clinicians the data they need to propel your drugs through the clinic and keep patients safe.

April 25 - 27, 2011, Boston, Massachusetts, USA

Companion Diagnostics Forum
The conference will take an in-depth look at challenges with implementing drug-diagnostic co-development, regulatory hurdles to overcome, best practices in the diagnostics field and approaches for handling drug response variability for clinical and commercial success.

April 27 - 29, 2011, Philadelphia, Pennsylvania, USA

Personalized Medicine: Promises and Perils for Community Oncology and Payers
This is an interactive workshop bridging Community Oncologist and Payers in open dialog regarding Personalized Medicine.

April 29 - 30, 2011, Grand Rapids, Michigan, USA

European Perspectives in Personalised Medicine
This conference will bring together key stakeholders of the research community and the healthcare sector to identify the developments needed in order to contribute to the research for Personalised Medicine at European and national level, in the frame of the Innovation Union and beyond.

May 12 - 13, 2011, Brussels, Belgium

10th Annual Systems Biology Symposium, Systems Biology & P4 Medicine
Internationally recognized speakers will discuss current research, new findings, advances in experimental technologies and more, all within the framework of solving global health challenges.

May 15 - 16, 2011, Seattle, Washington, USA

Personalized Medicine 4.0: Pharmacogenomics and Consumer Genetic Testing
The fourth annual one-day conference focused on the perspectives of non-profit and corporate research, biotechnology, academic, and diagnostic leaders with concentration on how the evolving landscape is revolutionizing medical care. The conference will explore what happens "on the ground" when personalized medicine is put into practice, and what that means for caregivers and patients, as well as for the industries that develop products for personalized medicine.

May 26, 2011, San Francisco, California, USA

2nd Annual Personalized Medicine Convention The aim of the PerMediConis to holistically address the innovative but very complex issue of personalized medicine and to bring together influential scientists, researchers, biotechnologists, pharmacologists, diagnostic experts, IT specialists, service providers and certification inspectors, as well as policymakers, government officials, and funding providers, some of whom still work completely independently of each other, so that they can engage in an interdisciplinary dialogue.

June 21 - 22, 2011, Colonge, Germany

WORLDDx Congress
Delivering practical strategies for biomarker improvement and patient stratification, WORLDx Congress will help you respond to rapidly evolving regulations, changing reimbursement paradigms, and the alliance management scenarios unique to the diagnostics industry. Here you can build a solid infrastructure of reliable partnerships and commercialization mechanisms, in order to put your research and discovery technology to use in the most practical and profitable manner.

July 18 - 20, 2011, Baltimore, MD, USA

Next Generation Dx Summit
The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, and Translating Proteomics & Metabolomics into the Clinical Laboratory) is designed to bring together all of the major players in the evolving areas of diagnostics. This year, we are introducing proteomic and metabolomic technologies that are making their way into clinical diagnostics.

August 23 - 25, 2011, Washington DC, USA

The ADAPT 2011 Personalized Therapy Congress
The benefits to the patient, as well as the business opportunities a targeted therapy approach present are driving this change. The ADAPT 2011 Congress brings together senior executives and key strategic players from across Pharma, Diagnostic, Clinical and Informatics to work together to shape the future of personalized medicine towards a targeted approach. Case studies, discussion groups, short courses and technology highlights will explore the relationship between biomarkers and the promise of personalized therapy, how circulating tumor cells (CTCs) could better track the progression of cancer, and adaptive trials that bring targeted therapies to market.

September 7 - 9, 2011, Philadelphia, PA, USA

World Biomarkers and Companion Diagnostics Summit Asia
The World Biomarkers and Companion Diagnostics Summit Asia will serve as Asia’s only global meeting place for pharmaceutical and biotech professionals to focus exclusively on how to seize this near term opportunity to deliver better, safer drugs to the Asian market with drug-diagnostic development.

September 12 - 14, 2011, Hong Kong

Cleveland Clinic Center for Personalized Healthcare Inaugural Personalized Healthcare Summit
The theme of the summit is "Personalizing Patient Care: Building an Innovative Delivery Model for Personalized Healthcare." The summit agenda is centered around “making personalized healthcare informed by genetics & genomics practical.” High profile healthcare, education and business leaders will be assessing past practices, integration of present applications, and emerging applications. The summit will specifically target areas of Clinical Integration, Education, Business Models, and Societal Issues (Healthcare reform).

September 19 - 20, 2011, Cleveland, Ohio, USA

Personalized Medicine: A Search for Tailored Therapeutics
This symposium, presented by the New York Academy of Sciences, will review the new technologies currently being used to profile the unique causes of human disease, including quantitative genomic changes that result in abnormal protein expression in disease, advances in quantitative proteomics, clinical screening data and advancing technologies within the biotech arena that may ultimately make personalized medicine a reality.

September 20, 2011, New York, New York, USA

2nd World Pharmacogenomics Summit
The 2nd World Pharmacogenomics Summit presented by Hanson Wade focuses on biomarkers, drug safety/efficacy and clinical decision making, with contribution from J&J, EMA, GSK, AZ, Roche, Boehringer, MPI, Merck Serono, Karolinska Institutet, EPEMED, Taisho Pharma, Lundbeck and many others.

October 25 - 27, 2011, Munich, Germany

7th Annual Burrill Personalized Medicine Meeting
The 7th Annual Burrill Personalized Medicine Meeting provides attendees with a detailed "window" into the personalized medicine world from where the science had led us to what hurdles need to be overcome and the policies that are required so that personalized medicine becomes part of the solution to true healthcare reform. The conference will also focus on the business and financial aspects of personalized medicine. The agenda features leading authorities across the spectrum of personalized medicine and the meeting encourages participation, focusing on intimate discussions with small groups of panelists and expert moderators, and encourages participation from the expert audience. As such the meeting will appeal to researchers, drug/diagnostics/tools developers, payors, investors/analysts and public policy/regulators.

November 2 - 3, 2011, San Francisco, California, USA

7th Annual Partners HealthCare Center for Personalized Medicine Conference
The annual conference is dedicated to exploring the opportunities to make personalized medicine a reality.

November 9 - 10, 2011, Cambridge, Massachusetts, USA

Keystone Symposia: Complex Traits: Genomics and Computational Approaches
Without mastering the large-scale molecular data that underlies pathophysiological states, without sophisticated mathematical algorithms capable of data integration, and without an appropriate informatics infrastructure to apply these algorithms and translate the results into manageable bites of information that can be consumed by physicians and patients, efforts to realize the dream of personalized medicine will be difficult to achieve. Towards this end of realizing the promise of personalized medicine, the Keystone Symposia meeting on Complex Traits: Genomics and Computational Approaches will focus on three different areas: 1) Methods for integrating diverse, large-scale, high-dimensional data with clinical phenotypes to construct predictive models (e.g., networks) of disease; 2) Application of integrative biology approaches that combine large-scale molecular and clinical phenotype information to elucidate the underlying causes of disease and to prioritize drug targets and biomarkers; and 3) Technological advances that will drive a dramatic explosion in data that will enable better models of disease and solutions to address the problem of how we will enable others to share big data, interact with complex models and refine those models to improve our understanding of disease and associated biological processes.

February 20 - 25, 2012, Breckenridge, Colorado, USA

Abstract deadline: October 20, 2011

World Theranostics Congress USA 2011
The World Theranostics Congress is a three day strategic conference and a parallel exhibition. The conference features senior executives from pharma, biotech and diagnostics companies case studying scientific innovation and excellence, biomarkers, computational biology, partnership dynamics and more.

November 15 - 17, 2011, San Diego, California, USA

Personalized Medicine World Conference (PMWC) 2012
Launched by Silicon Valley entrepreneurs and investors in 2009, the Personalized Medicine World Conference (PMWC) is the only fully integrated conference to examine Personalized Medicine through an industry lens. PMWC brings together the thought-leaders of business, government, healthcare-delivery, research and technology into one information-rich, two-day conference.

January 23 - 24, 2012, Silicon Valley, California, USA

Up Close and Personalized, International Congress on Personalized Medicine (UPCP 2012)
The main focus of the Up Close and Personalized Congress is to examine the essential clinical, genomic, proteomic, metabolomic, pharmacogenomic and biomarker data necessary to predict, prevent and treat major medical conditions concerning metabolism (diabetes and obesity), cardiovascular complications and cancer. In addressing the need and challenge for narrowing the gap between knowledge and clinical practice, one of the key themes will be to explore bio-informatic tools, algorithms, artificial intelligence techniques, decision support systems and other new platforms for predicting clinical outcome and better tailoring treatment modeling to the individual patient. Furthermore, as the patient is at the center of our concern we will also discuss modalities to “empower” the patient.

February 2 - 5, 2012, Florence, Italy

19th International Molecular Med Tri-Conference
The 19th Annual Molecular Medicine Tri-Conference - CHI's flagship event. The 2012 program will feature compelling talks from industry, academia, government, and healthcare organizations. Spanning five days in 2012, the event now includes more pre-conference activities including: 2 partnering forums, 5 symposia, and 11 short courses. Join over 3,000 attendees in interactive lectures, discussions, and various receptions as a way to facilitate networking opportunities and hearing differing views and perspectives on poignant issues facing you and our industry today.

February 19 - 23, 2012, San Franscisco, California, USA

Share this